Pfizer stock: BofA raises target for Pfizer stock to USD 29.00
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Bank of America has raised its price target for Pfizer stock (PFE) to USD 29.00 from USD 27.00, maintaining a Neutral rating. This adjustment comes after Pfizer reported second-quarter 2026 revenue of USD 15.03 billion, an operational increase of 1.00 percent year-over-year. Despite the raised target, it remains below Pfizer's current NYSE price of USD 29.85 as of October 21, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.